Indeed we note high levels of MYC in the lesions, which has been shown previously to be a strong collaborating event with RUNX2 in lymphoid tumours (Blyth et al., 2001; Blyth et al., 2006). The gene discussed is MYC; the disease is lymphoid neoplasm.